Reportlinker Adds Medical Imaging Markets

NEW YORK, April 26, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Medical Imaging Markets

http://www.reportlinker.com/p048845/Medical-Imaging-Markets.html

The purpose of this TriMark Publications report is to describe the specific market segment of the diagnostics market sector called medical imaging. Medical imaging can be categorized into nine main modalities: X-ray, ultrasound, computed tomography (CT), positron emission tomography (PET), single photon emission tomography (SPECT), magnetic resonance imaging (MRI), nuclear medicine (NM), mammography and fluoroscopy. Globally, X-ray is the most frequently used imaging procedure with about 108 million X-ray exams per year. MRI is second with 26 million examinations per year. PET, SPECT, CT and nuclear medicine rank third with 30 million examinations per year. Picture archiving and communication systems (PACS) and contrast agents are the sub-segments in medical imaging market that have gained significant growth in recent years. As a result of these medical imaging advancements, the multi-slice systems are generating large volumes of data, and this creates demand for data storage, 3-D visualization and analysis. As such, the global medical imaging industry is primed to experience significant growth through the next decade. This report surveys almost all of the companies known to be marketing, manufacturing or developing medical imaging equipment and supplies in the world. Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position. Detailed tables and charts with sales forecasts and market share data are also included.

TABLE OF CONTENTS

1. Overview 11

1.1 Statement of Report 11

1.2 Scope of this Report 11

1.3 Methodology 12

1.4 Executive Summary 13

1.4.1 Outlook for Medical Imaging 13

1.4.2 Outlook for Computed Tomography (CT) 13

1.4.3 Outlook for Magnetic Resonance Imaging (MRI) 13

1.4.4 Outlook for Positron Emission Tomography (PET) 14

1.4.5 Outlook for Single-Photon Emission Computed Tomography (SPECT) 14

1.4.6 Outlook for Hybrid Modalities 14

1.4.8 Outlook for Mammography 15

1.4.9 Outlook for Digital Radiography/Computed Radiography (DR/CR) 16

1.4.10 Outlook for Image-Guided Radiation Therapy (IGRT) 16

1.4.11 Outlook for Cardiac CT Imaging 16

1.4.12 Outlook for CT Angiography 17

1.4.13 Outlook for Nuclear Medicine in Cardiac Imaging 17

1.4.14 Outlook for MRI vs. SPECT in Cardiac Procedures 17

1.4.15 Outlook for Echocardiography in Cardiac Imaging 17

1.4.16 Outlook for Optical Coherence Tomography (OCT) 18

1.4.17 Outlook for Health IT 18

1.5 Market Drivers in Medical Imaging 18

1.5.1 Diagnostic Imaging Hardware 18

1.5.2 Miniaturization/Computing power 18

1.5.3 Fusion/Multimodality 18

1.5.4 Diagnostic Imaging Software 19

1.5.5 3D/4D Imaging 19

1.5.6 Computer-Aided Detection (CAD) 19

1.5.7 Workflow Automation 19

1.5.8 Enabling Technologies 19

1.5.9 Digitization 19

1.5.10 Client-Server Technology 20

1.5.11 Interoperability and Standardization 20

1.6 Challenges in Medical Imaging 20

1.6.1 Legal and Regulatory Constraints 20

1.6.1.1 U.S. Healthcare Reform 20

1.6.1.2 Reimbursement 20

1.6.1.3 Intellectual Property Protection for Imaging Software 21

1.6.1.4 OEM Relationships 21

1.6.1.5 Budgetary Concerns 21

1.6.1.6 Equity Funding Constraints 22

1.7.3 Breakeven Analysis for Magnetic Resonance Imaging (MRI) 24

1.7.4 Reimbursement and Patient's Access for Medical Imaging in the U.S. 24

2. Medical Imaging Technologies: A Brief Overview 26

2.1 General X-rays in Medical Imaging 26

2.1.1 Applications 26

2.2 Computed Tomography (CT) in Medical Imaging 27

2.2.1 Milestones in X-Ray CT 27

2.2.2 Evolution of Multislice Spiral CT Scanning 27

2.2.3 Computed Tomography (CT) Applications 27

2.2.4 Main Drivers in X-ray CT 28

2.2.5 Detector Channels per CT 28

2.2.6 Advances in X-Ray CT 28

2.2.7 Scanning Procedure 28

2.2.8 Common Uses of CT Scanners 28

2.2.9 Benefits of CT Scanning 29

2.2.10 Risks Involved in CT Scanning 29

2.3 Magnetic Resonance Imaging (MRI) 29

2.3.1 Safety Measures 30

2.3.2 Magnets in MRI Scanners 30

2.3.3 Technology of MRI Scanner 31

2.3.4 Visualization in MRI Scanner 31

2.3.5 Advantages of MRI 31

2.3.6 Disadvantages of MRI 32

2.4 Positron Emission Tomography (PET) 32

2.4.1 Common Uses of PET 32

2.4.2 PET Procedure 33

2.4.3 Benefits and Risks of PET Scans 33

2.4.4 Limitations of PET 33

2.4.5 Current Trends in PET and Hybrid Systems Design 33

2.4.6 Trends in PET Instrumentation 33

2.4.7 PET/CT 34

2.4.7.1 Advances in PET/CT Hybrid Modality 34

2.4.7.2 PET/CT Cancer Imaging 34

2.4.7.3 PET Neuroimaging 35

2.4.7.4 PET Cardiac Imaging 35

2.5 Single Photon Emission Computed Tomography (SPECT) 35

2.5.1 SPECT vs. PET 36

2.5.2 SPECT/CT Cancer Imaging 36

2.5.3 SPECT Neuroimaging 37

2.5.4 SPECT Cardiac Imaging 37

2.6 Ultrasound (US) 37

2.6.1 Ultrasound Machine 38

2.6.2 Different Types of Ultrasound 38

2.6.3 3D Ultrasound 38

2.6.4 Doppler Ultrasound 38

2.6.5 Uses of Ultrasound in Obstetrics and Gynecology 39

2.6.6 Uses of Ultrasound in Cardiology 39

2.6.7 Uses of Ultrasound in Urology 39

2.6.8 Ultrasound: Women's Preferred Imaging Modality 39

2.7 Mammography 39

2.7.1 Uses of Mammography 40

2.7.2 Mammography Equipment and Procedure 40

2.7.3 Benefits vs. Risks of Mammography 41

2.8 Fluoroscopy 41

2.9 Digital Radiography (DR) 42

2.10 Computed Radiography (CR) 42

2.11 Image-Guided Radiation Therapy 42

2.12 Cardiac CT Imaging 43

2.13 CT Angiography 43

2.14 Nuclear Medicine in Cardiac Imaging 44

2.15 Echocardiography in Cardiac Imaging 44

2.16 Optical Coherence Tomography (OCT) 44

2.17 Radioisotopes in Medicine 45

2.17.1 Diagnostic Techniques in Nuclear Medicine 45

2.17.2 Diagnostic Radiopharmaceuticals 46

2.17.3 Supplies of Radioisotopes 46

2.17.4 Contrast Media in Medical Imaging 47

2.17.5 Pricing Trends in Contrast Media 49

2.17.6 Economics of Contrast Agents 49

2.17.6.1 Reimbursement and Contrast Media 49

2.17.6.2 Negotiations on Pricing 49

2.17.7 Pricing in CT Contrast Agents 49

2.17.8 MRI Contrast Agents 50

2.17.8.1 Pricing in MRI Contrast Agents 51

2.17.9 Ultrasound Contrast Agents 52

3. Market Analysis 53

3.1 Medical Imaging and Information Technology Industry 53

3.2 Medical Imaging: Revenue Scenario in 2009 54

3.3 Popular Imaging Systems in 2009 54

3.4 Spending in IT Infrastructure 55

3.4.1 Clinical IT Spending 55

3.5 Global Market for Medical Imaging 55

3.5.1 Global Medical Imaging Market by Modality 56

3.6 Global Market for General X-Rays 57

3.7 Global Market for Ultrasound (US) 58

3.7.1 Global Market for Portable Ultrasound 59

3.8 Global Market for Magnetic Resonance Imaging (MRI) 60

3.9 Global Market for Computed Tomography (CT) 62

3.10 Global Market for Cardiovascular X-Ray 63

3.11 Global Market for Nuclear Medicine 64

3.11.1 Global Market for SPECT/PET 65

3.11.2 Long-Term Opportunities in SPECT in the Context of Technetium Shortage 67

3.11.3 High Energy Uranium (HEU) vs. Low Energy Uranium (LEU) 67

3.11.4 Effect of the Technetium Shortage on the SPECT Market 67

3.11.5 Improved Efficiency of New SPECT Cameras 67

3.11.6 New Radiopharmaceuticals in Nuclear Procedures 67

3.11.7 New Cardiology Products 68

3.12 Global Market for PET/CT 68

3.13 Global Oncology Biomarkers Market 69

3.15 Global Medical Displays and Post-Processing Software Market 72

3.15.1 Selected Medical Imaging Software 73

3.16 Global Market for Connectors in the Medical Electronics Market 73

3.17 North American Market for Medical Imaging 74

3.17.1 North American Market for Magnetic Resonance Imaging (MRI) 75

3.17.2 U.S. Market for Computed Tomography (CT) 76

3.17.3 U.S. Market for Multi-Slice CT Scanners 77

3.17.4 U.S. Market for SPECT and PET Radiopharmaceuticals 78

3.17.5.1 Medicare Payment for SPECT/CT Procedures in the U.S. 80

3.17.6 U.S. Market for Positron Emission Tomography (PET) 81

3.18 Radiology Practice in the U.S. 83

3.19 U.S. Market for Brachytherapy Products 84

3.20.2 Advances in Mammography in the U.S. 87

3.20.4 U.S. Market for Partial Breast Irradiation 88

3.20.5 Trends in Breast Cancer Mortality in the U.S 89

3.20.6 Medicare Reimbursement for Mammography Services in the U.S. 90

3.20.7 U.S. Market for Irradiated Microspheres for Liver Cancer 91

3.20.8 U.S. Market for Radiation Therapy 92

3.23 U.S. Market for Healthcare IT 102

3.23.1 EMR Adoption 102

3.23.2 Legitimacy of PHRs 103

3.23.3 Cost Containment 103

3.23.4 Emergence of Alternate Care Delivery Models 103

3.23.5 War on Medicare Fraud 103

3.23.6 Focus on Outbreak Preparedness 103

3.23.7 Intensification of Patient Safety Initiatives 103

3.23.8 Short Supply of Healthcare Professionals 103

3.23.9 Storage and Business Continuity Concerns 104

3.23.10 Physician Groups Joining Healthcare Systems 104

3.23.11 U.S. Market for Healthcare IT 104

3.23.12 Software Applications and Market in Medical Imaging 105

3.24 Medical Imaging in Canada 105

3.24.1 Funding for Medical Imaging Services in Canada 107

3.24.2 Medical Imaging Fees in Canada 107

3.24.3 Medical Imaging Market in Canada 108

3.24.4 Canadian Demand for Medical Imaging Products 109

3.24.5 Medical Imaging in Northern Canada 109

3.24.6 Nuclear Medicine in Canada 112

3.25 Medical Imaging in Europe 115

3.25.1 Growing Applications in Interventional Cardiology 115

3.25.2 Sluggish Growth of Cardiac MRI 116

3.25.3 Trend of Miniaturization and Echocardiography 116

3.25.4 Future of Medical Imaging in Europe 116

3.25.6 Picture Archiving and Communication Systems Market in Europe 117

3.25.7 European Market for Digital Radiography (DR) 118

3.25.8 European Market for Computed Radiography 119

3.25.9 European Market for MRI 119

3.25.10 Mammography in Europe 120

3.26 Emerging Markets in Medical Imaging 122

3.26.1 Medical Imaging in China and India 122

3.27 Medical Imaging Market in China 125

3.27.1 Market for Ultrasound in China 126

3.27.2 Multinational Medical Imaging Companies in China 127

3.28 Medical Imaging Market in India 127

3.28.1 Equipment Providers in India 128

3.28.2 Off-shoring of Radiology 128

3.28.3 Medical Imaging Industry in India 129

3.28.4 MRI Market in India 129

3.28.5 Nuclear Medicine in India 130

3.28.6 Indian Market for CT Systems 131

3.28.7 X-Ray Market in India 133

3.28.8 Digital Radiography in India 134

3.28.9 Cath Labs in India 135

3.28.10 Ultrasound Equipment Market in India 137

3.28.11 Endoscopy Equipment Market in India 139

3.28.12 Nuclear Medicine Equipment and Consumable Market in India 139

4. Funding Arrangements for Medical Imaging Procedures

4.1 The Working of the Systems 141

4.1.1 Waiting Times for Medical Imaging Procedures in Canada 141

4.1.2 Funding for Medical Imaging in France 142

4.1.3 Funding for Medical Imaging in Germany 142

4.1.4 Funding of Medical Imaging in New Zealand 143

4.1.5 Funding for Medical Imaging in the U.K. 144

4.1.6 Funding for Medical Imaging in the U.S. 146

4.1.7 Funding of Medical Imaging in Japan 149

5. Health and Medical Imaging Expenditures in OECD Countries 150

5.1 Diagnostic Imaging Equipment and Utilization Statistics 151

5.1.2 Gamma Cameras per Million of Population in OECD Countries 153

5.2 Utilization of Medical Imaging Modalities in OECD Countries 157

6. Company Profiles 161

6.1 3mensio Medical Imaging BV 161

6.2 Agfa HealthCare 161

6.3 Analogic Corporation 162

6.3.1 Computed Tomography Systems and Subsystems 162

6.3.2 Magnetic Resonance Imaging Power Solutions 162

6.3.3 Specialized Ultrasound Solutions 162

6.3.4 Digital Radiography Subsystems 163

6.3.5 Radiation Therapy Solutions 163

6.4 Ardent Sound, Inc 163

6.5 Avreo, Inc. 163

6.6 Bard Access Systems, Inc. 164

6.7 Biosound Esaote, Inc, 164

6.8 BK Medical 165

6.9 BRIT Systems, Inc. 166

6.10 Canon U.S.A., Inc. 166

6.11 Candelis 167

6.12 Cedaron Medical, Inc. 168

6.12.2 OrthoCare 168

6.13 Chison Medical Imaging, Co., Ltd. 168

6.14 DR Systems, Inc. 169

6.15 Focus Surgery, Inc. 170

6.15.1 Sonablate 170

6.16 Fonar Corporation 170

6.16.1 The Upright MRI 171

6.16.2 Fonar 360 171

6.17 Fujifilm Medical Systems USA, Inc. 171

6.18 Fukuda Denshi Co., Ltd. 172

6.19 GE Healthcare 173

6.20 Hitachi Medical Corporation 177

6.21 Hermes Medical Solutions 178

6.22 Hologic, Inc. 182

6.22.1 Hologic's Medical Imaging Product Offerings 182

6.22.1.1 Selenia Dimentions 2D Full Field Digital Mammography System 182

6.22.1.2 Screen-Film Mammography Systems 182

6.22.1.3 R2 ImageChecker Digital CAD 183

6.22.1.4 SecurView Diagnostic Workstations 183

6.22.1.5 Discovery 184

6.23 Imaging Diagnostic Systems, Inc. 184

6.23.1 CTLM 184

6.23.2 Invivo Corporation 185

6.23.3 DynaSuite Neuro 185

6.23.4 DynaCAD for Breast 185

6.23.5 DynaCAD for Prostate 186

6.24 InfiMed, Inc. 186

6.25 InSite One, Inc. 186

6.26 Intelerad Medical Systems 187

6.27 Konica Minolta Medical Imaging USA, Inc. 188

6.27.1 Regius Model 210 188

6.27.2 Xpress CR 189

6.27.3 Regius Nano CR 189

6.27.4 ImagePilot 189

6.27.5 IQue CR 190

6.27.6 FlexDR C30 190

6.27.7 Xpress DR Digital Radiography 190

6.28 Lantheus Medical Imaging, Inc. 191

6.29 Lumedx 191

6.30 MEDIAN Technologies S.A. 192

6.30.1 LMS-Lung 192

6.30.2 LMS-Lung/Track 192

6.30.3 LMS-Liver 193

6.31 Medis Medical Imaging Systems BV 193

6.32 Medison America, Inc. 194

6.33 Medtronic, Inc. 194

6.33.1 PoleStar 194

6.33.2 StealthStation i7 Integrated Surgical Navigation System 195

6.33.3 O-arm 195

6.33.4 StealthViz 195

6.34 NanoScan Imaging, LLC 195

6.34.1 N1177 196

6.35 NovaRad 196

6.36 The Phantom Laboratory 196

6.36.1 Catphan 197

6.36.2 Magphan 197

6.36.3 ADNI Magphan 197

6.36.4 Specphan 197

6.36.5 Rando 198

6.36.6 RSVP Phantom Head 198

6.36.7 RSVP Phantom Pelvis 198

6.36.8 Phantom Patient 199

6.36.9 Sectional Phantoms 199

6.36.10 Liqui-Phil 199

6.37 Philips Healthcare 200

6.38 Sectra Medical Systems S.L. 202

6.39 Schick Technologies, Inc. 203

6.40 ScImage, Inc. 204

6.41 Siemens Healthcare 205

6.42 Shimadzu Corporation 210

6.43 SonoSite, Inc. 211

6.44 Spacelabs Healthcare, Inc. 211

6.44.1 Sentinel 212

6.45 Syntermed, Inc. 212

6.45.1 Emory Cardiiac Toolbox 212

6.45.2 Syntermed Live 212

6.45.3 Nuclear Report Professional 212

6.45.4 NeuroQ 212

6.45.5 EQuAL 212

6.46 TeraMedica, Inc. 213

6.47 TeraRecon, Inc. 213

6.48 TomTec Imaging Systems GmbH 214

6.49 Toshiba America Medical Systems, Inc. 214

6.49.1 Infinix-i systems 214

6.49.4 Viamo 215

6.49.5 Radrex-i 216

6.50 UltraRAD Corporation 216

6.51 Varian Medical Systems, Inc. 217

6.52 Vepro 217

6.53 Vidar Systems Corporation 217

6.54 Vital Images, Inc 218

6.55 VuCOMP, Inc. 218

6.56 Xoran Technologies, Inc. 219

Appendix 1: Medical Imaging Technologies 221

Appendix 1.1: Ultrasound Systems 221

Appendix 1.2: Computed Tomography 222

Appendix 1.3: Magnetic Resonance Imaging (MRI) 222

Appendix 1.4: Digital X-Ray 223

Appendix 1.5: Positron Emission Tomography (PET) 224

Appendix 2: Current and Future Trends in Medical Imaging Electronics 226

Appendix 2.1: Power Management 226

Appendix 2.2: Miniaturization and Integration 226

Appendix 3: Supply of Medical Radioisotopes 228

Appendix 3.1: Potential for New Reactors 229

Appendix 3.2: Processing Capacities and Restraints 230

Appendix 4: Opportunities in the Middle East for Healthcare and Medical Imaging

Products 232

Appendix 4.1: The Largest U.S. Customers in the Middle East Region 232

Appendix 4.2: U.S. Exports of Medical Imaging Products to the Middle East 233

Appendix 5: Value of Radiation Therapy and Medical Imaging 234

Appendix 5.1: Effective Use of Medical Radiation 235

Appendix 5.2: Innovations to Reduce Radiation Dose 235

Appendix 5.3: Innovations in CT Imaging 235

Appendix 5.4: Effectiveness of Radiation Therapy 236

Appendix 5.5: Efforts to Minimize Radiation Dose 237

Appendix 5.6: New Dose Check Features 237

INDEX OF FIGURES

Figure 1.1: Major Drivers of Healthcare Costs in the U.S., 2010 22

Figure 1.2: Growth in Medicare Allowed Services and Charges for Medical Imaging

in the U.S., 1995-2009 23

Figure 1.3: Hospital Imaging Volume Projections in the U.S., 2005-2015 25

Figure 3.1: Medical Imaging Markets by Region, 2009 56

Figure 3.2: Global Medical Imaging Market by Modality, 2009 57

Figure 3.3: Global Market for General X-Rays, 2009-2016 58

Figure 3.4: Global Market for Ultrasound, 2009-2016 59

Figure 3.5: Global Market for Portable Ultrasound Equipment, 2009-2014 60

Figure 3.6: Global Magnetic Resonance Imaging (MRI) Market by Geography, 2010 61

Figure 3.7: Global Market for MRI, 2009-2016 61

Figure 3.8: Global CT Market, 2004-2009 62

Figure 3.9: Global Market for Computed Tomography, 2009-2016 63

Figure 3.10: Global Market for Cardiovascular X-Ray, 2009-2016 64

Figure 3.11: Market for Nuclear Medicine, 2009-2016 65

Figure 3.12: Estimated Lifetime Risks for Alzheimer's by Age and Sex in the U.S.

66

Figure 3.13: Global Market for SPECT/PET, 2010-2015 66

Figure 3.14: Global Market for PET/CT, 2010-2015 68

Figure 3.15: Global Market for Biomarkers, 2009-2014 69

Figure 3.16: Biomarker Patent Filings by Type of Cancer, 2010 71

Figure 3.17: Global Market for Breast Cancer, 2009-2016 72

Figure 3.18: Global Market for Medical Displays and Post-Processing Software,

2009-2014 72

Figure 3.19: Global Market for Connectors in the Medical Electronics, 2009-2014

74

Figure 3.20: North American Market for Medical Imaging Equipment, 2009-2016 75

Figure 3.21: North American Market for Magnetic Resonance Imaging, 2010-2015 76

Figure 3.22: U.S. Market for Computed Tomography (CT), 2008-2015 77

Figure 3.23: Market for Multi Slice CT Systems in the U.S., 2008-2015 78

Figure 3.24: U.S. Market for Radiopharmaceuticals, 2009-2017 79

Figure 3.25: U.S. Market for SPECT, 2009-2017 80

Figure 3.26: U.S. Market for PET, 2009-2017 82

Figure 3.27: U.S. Market for Brachytherapy Products, 2008-2016 85

Figure 3.28: New Breast Cancer Incidence in North America, 2009-2017 86

Figure 3.29: U.S. Market for Mammography, 2008-2013 88

Figure 3.30: U.S. Market for Partial Breast Irradiation, 2008-2016 89

Figure 3.31: Age-Specific Death Rates Due to Breast Cancer by Age Group, U.S.,

1996 and 2006 90

Figure 3.32: U.S. Market for Irradiated Microspheres for Liver Cancer, 2008-2016

92

Figure 3.33: Age-Specific Incidence Rate of Breast Cancer in U.K., 2007 94

Figure 3.34: U.S. Market for PACS, 2008-2015 95

Figure 3.35: Number of U.S. Hospitals with PACS Installed, 2000-2008 96

Figure 3.36: Number of U.S. Hospitals with Installed PACS, 2000-2008 96

Figure 3.37: Replacements and New PACS Purchases, 2000-2008 97

Figure 3.38: PACS Installation by Bed Size in the U.S., 2000-2008 98

Figure 3.39: PACS Modalities Installations in the U.S. Hospitals, 2005 and 2008

98

Figure 3.40: PACS Company Market Share, 2008 99

Figure 3.41: PACS Image Distribution in Hospital Departments, 2006-2008 100

Figure 3.42: PACS Images Accessibility by Physician, 2006-2008 101

Figure 3.43: RIS and PACS Interface, 2005-2008 102

Figure 3.44: U.S. Market for Healthcare IT, 2009-2014 104

Figure 3.45: U.S. Market for Software Applications, 2009-2014 105

Figure 3.46: Canadian Market for Medical Imaging Modalities, 2009-2014 106

Figure 3.47: Percent Distribution of Diagnostic Imaging Examinations in Canadian

Hospitals, 2006 106

Figure 3.48: Medical Imaging Market Leaders and their Market Share in Canada,

2009 109

Figure 3.49: Types and Breakdown of Nuclear Medicine Procedures that Can be

DoneUsing Tc-99m 113

Figure 3.50: Global Nuclear Medicine Market Share by Reactor, 2008 114

Figure 3.51: Percent Global Market for Tc-99m by Geography/Country and Doses 115

Figure 3.52: Western European Market for Medical Imaging Equipment, 2009-2016

116

Figure 3.53: Imaging Diagnostics Market in Central Europe, 2009-2012 117

Figure 3.54: European Market for PACS, 2009-2016 118

Figure 3.55: European Market for Digital Radiography, 2009-2016 118

Figure 3.56: European Market for Computed Radiography, 2009-2016 119

Figure 3.57: European Market for Magnetic Resonance Imaging (MRI), 2010-2015 120

Figure 3.58: Percentage of Causes of Death in Women 121

Figure 3.59: Diagnostic Imaging Market in Emerging Markets, 2009-2016 122

Figure 3.60: Diagnostic Imaging Equipment Installations in the Two Emerging

Economies, 2009 123

Figure 3.61: Middle-class population as a % of the total population in India,

1998-2010 124

Figure 3.62: Market for Medical Imaging Equipment in Greater China, 2009-2016

125

Figure 3.63: Market for Ultrasound in China, 2009-2014 126

Figure 3.64: Market for Medical Imaging Equipment in India, 2009-2016 128

Figure 3.65: Number of MRI Units in India, 2009 129

Figure 3.66: Indian CT Systems Market by Value, 2009 132

Figure 3.67: Indian CT Systems Market by Unit, 2009 132

Figure 3.68: Market for X-Ray in India, 2006-2009 133

Figure 3.69: Indian X-Ray Equipment Market by Unit (%), 2009 135

Figure 3.70: Indian Market for Cath Labs by Value, 2008-2009 135

Figure 3.71: Indian Cath Lab Market by Units, 2008-2009 136

Figure 3.72: Indian Ultrasonic Equipment Market Share by Segment, 2007 137

Figure 3.73: Percent Indian Market Share in Endoscopy by Segment, 2009 139

Figure 3.74: Indian Market for PET Systems and Gamma Camera, 2009 140

Figure 5.1: Public and Private Expenditure on Health % of GDP in Select OECD

Countries 150

Figure 5.2: Angiography Units per Million of Population in OECD Countries 151

Figure 5.3: CT Scanners per Million of Population in OED Countries 152

Figure 5.4: Gamma Cameras per Million of Population in OECD Countries 153

Figure 5.5: Mammography Units per Million of Population in OECD Countries 154

Figure 5.6: MRI Scanners per Million of Population in OECD Countries 155

Figure 5.7: PET Scanners per Million of Population in OECD Countries 156

Figure 5.8: CT Exams per Scanner in OECD Countries 157

Figure 5.9: CT Exams per 1,000 of Population in OECD Countries 158

Figure 5.10: MRI exams per Scanner in the OECD countries 159

Figure 5.11: MRI Exams per 1,000 of Population in OECD Countries 160

Figure App. 1.1: Block Diagram of Imaging Ultrasound Equipment 221

Figure App. 1.2: Block Diagram of a Medical CT System 222

Figure App. 1.3: Block Diagram of a Medical MRI 223

Figure App 1.4: Block Diagram of Digital X-Ray 224

Figure App. 1.5: Block Diagram for Positron Emission Tomography 225

Figure App 2.1: Block Diagram of Portable Ultrasound System 226

Figure App. 3.1: Current Supply and Demand for Medical Radioisotopes, 2010-2024

229

Figure App. 3.2: Percent Market Share of Medical Radioisotopes by Reactor, 2010

230

Figure App. 4.1: U.S. Exports of Medical Products to the Middle East, 1996-2009

232

Figure App. 4.2: U.S. Exports of Medical Products to Israel, Saudi Arabia and

Turkey, 1996-2009 233

Figure App. 4.3: U.S. Exports of Medical Imaging Products to Israel, Saudi

Arabia and Turkey, 1996-2009 233

INDEX OF TABLES

Table 1.1: Code-Specific Impacts of CMS Medicare Physician Fee Schedule 21

Table 1.2: CT Technical Revenue: Breakeven at Various Levels of Utilization in

the U.S. 24

Table 1.3: MRI Technical Revenue: Breakeven at Various Levels of Utilization in

the U.S. 24

Table 1.4: Reimbursement Reductions and Effect on Contribution Margin in U.S.

Outpatient Imaging 25

Table 2.1: Properties of Scintillation Crystals in PET Imaging Systems 34

Table 2.2: Radioisotopes Used in Medical Imaging 47

Table 2.3: Comparative Data on X-Ray Contrast Media 47

Table 2.4: Properties of Low and Iso-Osmolar Contrast Agents 48

Table 2.5: A Sample of Common Radiological Contrasting Agents and Discount Rates

50

Table 2.6: Common MRI Contrast Agents and Discount Rates 51

Table 2.7: Common Ultrasound Contrast Agents and Discount 52

Table 3.1: Top Ten Imaging Systems Purchased, 2006-2009 54

Table 3.2: IT Spending in the U.S. Hospitals, 2010-2015 55

Table 3.3: Biomarkers Used in Cancer Diagnosis 70

Table 3.4: Medicare Payment Rated for SPECT/CT Procedures in the U.S., 2010 81

Table 3.5: Medicare Reimbursement for PET Services in the U.S., 2010 83

Table 3.6: Female Breast Cancer Risk Factors 86

Table 3.7: FDA Approved Mammography Systems, Breast Tests and Breast Implants,

2000-2010 87

Table 3.8: Medicare Reimbursement for Mammography Procedures, 2009 91

Table 3.9: Mortality Rate in European Countries, 1989-2006 93

Table 3.10: Number of New Cases and Rates of Breast Cancer in the U.K., 2007 94

Table 3.11: Sources of Operating Funds for Medical Imaging Equipment in Canada,

2007 107

Table 3.12: Canadian Fee Structure for Medical Imaging Procedures 107

Table 3.13: Imaging Modalities Available in Whitehorse General Hospital 110

Table 3.14: Imaging Equipment in Watson Lake Hospital and the Health Centers 111

Table 3.15: Imaging Equipment in Stanton Territorial Hospital 111

Table 3.16: Diagnostic Imaging Equipment in Northern Territory Hospitals 112

Table 3.17: Imaging Technologies in the Qikiqtani General Hospital 112

Table 3.18: Diagnostic Imaging Equipment Installations in China and India,

2000-2009 123

Table 3.19: Availability of Medical Imaging Equipment per Million Populations in

China and India, 2009 124

Table 3.20: Diagnostic Imaging Affordability in Emerging Economies 125

Table 3.21: Multinational Firms in China for Medical Imaging Products 127

Table 3.22: Installed Base of CT and MRI in India, China, Japan and Korea, 2010

129

Table 3.23: Medical Cyclotrons in India 130

Table 3.24: PET/CT Scanner Profile in India 131

Table 3.25: PET/CT Scanners: No. of Slices Used in India 131

Table 3.26: Imaging Protocols in PET/CT in India 131

Table 3.27: Drivers of X-Ray Industry in India 134

Table 3.28: Major Ultrasound Market Vendors in India 137

Table 3.29: Ultrasound Equipment Vendors in India 138

Table 4.1: Weeks Waited for Medical Imaging Procedures in Canada 142

Table 4.2: Reimbursement Rates for Medical Imaging Procedures in Germany 143

Table 4.3: Reimbursement Rates for Medical Imaging Procedures in New Zealand 144

Table 4.4: Non-Mandatory Tariffs for Medical imaging in the U.K, 2009-2010 145

Table 4.5: Number and Cost of Medical Imaging Services in the U.K., 2008-09 146

Table 4.6: Percent Distribution of Health Services Visit by Expected Source of

Payment, U.S. 147

Table 4.7: Cost of MRI and PET in Different States and Cities in the U.S. 147

Table 6.1: 3mensio's Product Portfolio 161

Table 6.2: Agfa's Medical Imaging Products 161

Table 6.3: Ardent's Product Portfolio 163

Table 6.4: Avreo's Radiology Workflow Solutions 164

Table 6.5: Bard's Imaging Products 164

Table 6.6: Biosound Esaote's Ultrasound Systems 165

Table 6.7: BK Medical's Product Portfolio 165

Table 6.8: BRIT System's Healthcare IT Solutions 166

Table 6.9: Canon's Medical Imaging Products 167

Table 6.10: Candelis' Software Solutions for Medical Imaging 167

Table 6.11: Chison's Ultrasound Product Portfolio 169

Table 6.12: DR System's Healthcare IT Solutions 170

Table 6.13: Fujifilm Medical Systems' Product Portfolio 172

Table 6.14: Fakuda's Ultrasound Products 172

Table 6.15: GE Healthcare's Medical Imaging Modalities and Contrast Media 173

Table 6.16: Hitachi's Medical Imaging Product Portfolio 177

Table 6.17: Hermes' Medical Imaging Software Solutions 178

Table 6.18: InfiMed's Product Portfolio 186

Table 6.19: InSite One's Software Solutions 187

Table 6.20: Intelerad's Software Solutions 188

Table 6.21: Lantheus' Contrast Agent Products 191

Table 6.22: Lumedx's Cardiovascular Information System Solutions 191

Table 6.23: Medis' Software for Various Medical Imaging Modalities 193

Table 6.24: Medison's Medical Imaging Products 194

Table 6.25: NovaRad's Product Portfolio 196

Table 6.26: Philips' Computed Tomography Systems 200

Table 6.27: Philips' Nuclear Medicine Products 201

Table 6.28: Philips' Radiography Systems 201

Table 6.29: Philips' Radiography/Fluoroscopy (R/F) Products 202

Table 6.30: Philips' Magnetic Resonance Imaging (MRI) Systems 202

Table 6.31: Philips' Mammography Systems 202

Table 6.32: Spectra's Product Portfolio 203

Table 6.33: Schick's Product Portfolio in Medical Imaging 204

Table 6.34: Sclmage's Product Portfolio 205

Table 6.35: Siemens' Product Portfolio 206

Table 6.36: Shimadzu's Product Portfolio 210

Table 6.37: TeraMedica's Portfolio of Solutions and Products 213

Table 6.38: TeraRecon's Portfolio of Imaging Solutions 213

Table 6.39: TomTec's Product Portfolio 214

Table 6.40: UltraRAD's Product Portfolio 216

Table 6.41: Vepro's Product Portfolio 217

Table 6.42: Vidar's Product Portfolio 217

Table 6.43: Vital Images' Product Portfolio 218

Table App. 3.1: Major Current 99Mo Producing Reactors, 2010 228

Table App. 3.2: Potential Reactor-Based Projects for 99Mo Production, 2010-2024

229

Table App. 3.3: Processing Capacity of Major Reactors, 2010 230

Table App. 3.4: Demand Scenarios for 99Mo, 2010-2025 231

To order this report:

: Medical Imaging Markets

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker